Explore the latest in hepatobiliary cancer, including advances in understanding the epidemiology, diagnosis, management, and prevention of the disease.
This narrative review describes the concept of transplant oncology, the role liver transplant can have in the treatment of neoplasms, and reviews outcomes after liver transplant for primary and secondary hepatic malignancies.
This secondary analysis of a randomized clinical trial investigates whether the presence of liver metastasis is an indicator of treatment resistance to immune checkpoint inhibitors (ICIs) in patients with advanced colorectal cancer.
This cohort study assessed the association of exposure to Agent Orange and hepatocellular carcinoma among Vietnam veterans.
This case report describes a patient in their early 50s who presented with epigastric pain and jaundice and had significantly decreased heart rate after admission.
This cohort study evaluates racial disparities among candidates for hepatocellular carcinoma liver transplant following a 6-month wait policy change.
This cohort study explores differences in recurrence-free survival and overall survival associated with tenofovir disoproxil vs entecavir after liver resection with curative intent in patients with hepatocellular cancer (HCC) related to hepatitis B virus (HBV).
This phase 3 randomized clinical trial evaluates the efficacy and safety of tislelizumab vs sorafenib as first-line treatment in patients with unresectable hepatocellular carcinoma.
This systematic review and meta-analysis evaluates the efficacy and safety of immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma with Child-Pugh class B liver function.
This nonrandomized controlled trial assesses the long-term survival and prognosis in patients who undergo liver transplant for nonresectable liver metastases resulting from colorectal cancer.
This cohort study investigates the association between antidepressant use and mortality risk in patients with hepatocellular carcinoma.
This prognostic study presents clinical validation of a novel 31-gene classifier that accurately predicts colorectal liver metastasis molecular subtypes as a secondary analysis of the large multicenter randomized clinical trial.
This observational study evaluated incidence of liver cancer and death from chronic liver disease among postmenopausal women by comparing intake of 3 or fewer servings of sugar-sweetened beverages per month vs intake of 1 or more sugar-sweetened beverages per day.
This narrative review compares the clinical benefit and safety profile of the recommended first-line and second-line drug regimens for advanced hepatocellular carcinoma.
This cross-sectional study uses data from the Centers for Disease Control and Prevention to evaluate trends in cancer mortality in the US Hispanic population overall and by cancer type, age, gender, and region from 1999 to 2020.
This cohort study investigates clinicopathologic and prognostic associations of hypercalcemia in patients with intrahepatic or extrahepatic cholangiocarcinoma.
This randomized clinical trial examines the addition of treatment with liposomal irinotecan to fluorouracil and leucovorin for patients with advanced biliary tract cancer.
This narrative review discusses the surgical and medical therapies and multidisciplinary treatment strategies for hepatocellular carcinoma.
This cohort study examines BRAF variant subtypes, classifying them and analyzing response to therapy in patients with intrahepatic cholangiocarcinoma.
This essay describes the author’s experience with a socially isolated patient who declined cancer treatment because he had no one to help him after transarterial radioembolization therapy.
This cohort study investigates demographic, clinical, and therapeutic factors associated with the risk of malignant neoplasms of the gastrointestinal tract after blood or marrow transplant.
Customize your JAMA Network experience by selecting one or more topics from the list below.